Artemis raises $9M for prenatal diagnostics
Artemis Health, maker of technology for prenatal diagnostics, has brought in $9 million of an expected $10 million round of equity, according to a filing with the SEC. The San Carlos, Calif. company is backed by Alloy Ventures, Mohr Davidow Ventures and Sutter Hill Ventures. It last raised financing in September 2008, bringing in $20 million in a third round of venture funding.
Artemis licenses diagnostics from Stanford
Exercising its recently raised $20 million third funding round, Artemis Health has licensed non-invasive prenatal diagnostic technology from Stanford University. Initially, it licensed intellectual property from Massachusetts General Hospital and the Massachusetts Institute of Technology but has mostly been working in stealth mode since.
The acquisition is expected to help Artemis develop a fetal monitoring system superior to a typical amniocentesis. For example, the Stanford technology could help identify trisomy disorders like Down syndrome more easily…. Continue Reading
MDV hires pros to find personalized medicine investments
Mohr Davidow Ventures, a Menlo Park, Calif. firm, has hired two biotech experts to help it make prudent investments in personalized healthcare companies. Essentially, they will look for startups that apply technology to give patients more control over their medical experiences, and to cut costs for care providers and drug developers.
Daniel Riskin — who actually worked as a surgeon before entering industry — and Phyllis Whiteley both have firsthand experience at biotechnology companies. Riskin, named… Continue Reading